FDA Drug Application (202129) for ZETONNA by TAKEDA GMBH

Back to FDA Applications sponsored by TAKEDA GMBH

Application Number202129
Product Number001
FormAEROSOL, METERED;NASAL
Dosage0.037MG/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZETONNA
Active IngredientCICLESONIDE

Active IngredientCount
List of drugs with Active Ingredient CICLESONIDE3


Back to FDA Applications sponsored by TAKEDA GMBH